Swarthmore Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-147,150
Closed -$7.35M 36
2020
Q3
$7.35M Hold
147,150
2.31% 21
2020
Q2
$6.49M Buy
147,150
+134,100
+1,028% +$5.73M 2.21% 21
2020
Q1
$490K Sell
13,050
-142,500
-92% -$6M 2.6% 19
2019
Q4
$6.85M Sell
155,550
-6,600
-4% -$277K 1.59% 27
2019
Q3
$6.68M Sell
162,150
-26,100
-14% -$1.07M 1.65% 23
2019
Q2
$7.55M Buy
188,250
+169,950
+929% +$6.43M 1.86% 19
2019
Q1
$706K Buy
+18,300
New +$664K 3.03% 17

Other funds holding IHI

Swarthmore Group's IHI Position: Q4 2020 in Review

Swarthmore Group sold out of iShares US Medical Devices ETF (IHI) in Q4 2020, closing a stake of 147,150 shares — an estimated $7.35M sold.

Swarthmore Group first reported a position in IHI in Q1 2019 and held it in 7 quarters. The position peaked at $7.55M in Q2 2019. 582 funds tracked by Wall St. Rank hold IHI as of Q4 2020.

  • Swarthmore Group reported no remaining iShares US Medical Devices ETF position as of Q4 2020 after selling out during the quarter.
  • Swarthmore Group sold 147,150 iShares US Medical Devices ETF shares in Q4 2020, an estimated $7.35M.
  • Swarthmore Group first reported a position in iShares US Medical Devices ETF in Q1 2019 and held it in 7 quarters.
  • Swarthmore Group's iShares US Medical Devices ETF position peaked at $7.55M in Q2 2019.
  • 582 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2020.

Based on Swarthmore Group's 13F filing for Q4 2020, filed 8 Feb 2021.